GT Biopharma Inc logo

GT Biopharma Inc

0
LTS:0RU9 (USA)  
€ 1147194.00 (0%) Jan 14
At Loss
P/B:
2.55
Market Cap:
€ 5.21M ($ 5.37M)
Enterprise V:
€ -4.33M ($ -4.46M)
Volume:
-
Avg Vol (2M):
-
Trade In:

GT Biopharma Inc Valuation Measures